Influenza-attributable burden in United Kingdom primary care

Epidemiology and Infection

Volumn 144, Issue 3, 2016, Pages 537-547

  Fleming, D M ^a   Taylor, R J ^b   Haguinet, F ^c   Schuck Paim, C ^b   Logie, J ^d   Webb, D J ^d   Lustig, R L ^b   Matias, G ^c  

^a Sage Analytica ^*  (United Kingdom)

^b SAGE Analytica LLC   (United States)

^c GSK   (Belgium)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Epidemiology; GP surveillance systems; infectious disease; influenza; influenza vaccines

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CONSULTATION; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; INFANT; INFECTION RISK; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; MALE; MORBIDITY; OTITIS MEDIA; PRESCRIPTION; PRIMARY MEDICAL CARE; PUBLIC HEALTH; RESPIRATORY TRACT DISEASE; SEASONAL VARIATION; UNITED KINGDOM; AGE; CLINICAL TRIAL; COMORBIDITY; FACTUAL DATABASE; GENERAL PRACTICE; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PRIMARY HEALTH CARE; SEASON; STATISTICS AND NUMERICAL DATA; VACCINATION; VIROLOGY; YOUNG ADULT;

ANTIINFECTIVE AGENT; INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; GENERAL PRACTICE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; OTITIS MEDIA; PRIMARY HEALTH CARE; SEASONS; UNITED KINGDOM; VACCINATION; YOUNG ADULT;

EID: 84960344879     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815001119     Document Type: Article

References (37)

1. Fleming DM, Elliot AJ. Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiology and Infection 2008; 136: 866-875.
2. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Communicable Disease and Public Health 2000; 3: 32-38.
3. Nicholson KG. Chapter 19. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. Oxford: Blackwell Sciences, 1998, pp. 221-223.
4. Miller E, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: A cross-sectional serological study. Lancet 2010; 375: 1100-1108.
5. Fleming DM, Zambon M, Bartelds AI. Population estimates of persons presenting to general practitioners with influenza-like illness, 1987-96: A study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands. Epidemiology and Infection 2000; 124: 245-253.
6. Fleming D, Harcourt S, Smith G. Influenza and adult hospital admissions for respiratory conditions in England 1989-2001. Communicable Disease and Public Health 2003; 6: 231-237.
7. Glezen WP, et al. Impact of respiratory virus infections on persons with chronic underlying conditions. Journal of the American Medical Association 2000; 283: 499-505.
8. Molinari N-AM, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25: 5086-5096.
9. Fleming DM, et al. The duration and magnitude of influenza epidemics: A study of surveillance data from sentinel general practices in England, Wales and the Netherlands. European Journal of Epidemiology 1999; 15: 467-473.
10. Elliot AJ, Cross KW, Fleming DM. Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990-2005. Journal of Public Health (Oxford) 2008; 30: 91-98.
11. Thompson WW, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003; 289: 179-186.
12. Thompson WW, et al. Influenza-associated hospitalizations in the United States. Journal of the American Medical Association 2004; 292: 1333-1340.
13. Pitman RJ, et al. Assessing the burden of influenza and other respiratory infections in England and Wales. Journal of Infection 2007; 54: 530-538.
14. Hardelid P, Pebody R, Andrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010. Influenza and Other Respiratory Viruses 2013; 7: 35-45.
15. Zambon MC, et al. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: An observational study. Lancet 2001; 358: 1410-1416.
16. Williams T et al. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Therapeutic Advances in Drug Safety 2013; 3: 89-99.
17. Pebody RG, et al. Influenza vaccination coverage in England, 2000-2008. Eurosurveillance 2008; 13: 19074.
18. The Flu Immunisation Programme 2012/13-Publications-GOV. UK (https://www. gov. uk/government /publications/the-flu-immunisation-programme-2012-13). Accessed 31 October 2013.
19. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997; 350: 1097-1099.
20. Office of National Statistics. Taxonomy, 2010 (http:// www. ons. gov. uk/ons/taxonomy/index. html?nscl=Population+ Estimates). Accessed 17 December 2013.
21. Sullivan KM, Monto AS, Longini IM. Jr Estimates of the US health impact of influenza. American Journal of Public Health 1993; 83: 1712-1716.
22. Schanzer DL, Schwartz B. Impact of seasonal and pandemic influenza on emergency department visits, 2003-2010, Ontario, Canada. Academic Emergency Medicine 2013; 20: 388-397.
23. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Report 1963; 78: 494-506.
24. Matias G, et al. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status. Influenza and Other Respiratory Viruses 2014; 8: 507-515.
25. Zhou H, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clinical Infectious Diseases 2012; 54: 1427-1436.
26. Thompson WW, et al. Time-series analyses of count data to estimate the burden of seasonal infectious diseases. Epidemiology 2012; 23: 839-842.
27. Yang L, et al. Validation of statistical models for estimating hospitalization associated with influenza and other respiratory viruses. PLoS ONE 2011; 6: e17882.
28. Gay NJ, et al. Estimating deaths due to influenza and respiratory syncytial virus. Journal of the American Medical Association 2003; 289: 2499.
29. Goldstein E, et al. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology 2012; 23: 829-838.
30. Christenson B, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal 2004; 23: 363-368.
31. Cocoros NM, et al. Obesity as a risk factor for severe influenza-like illness. Influenza and Other Respiratory Viruses 2014; 8: 25-32.
32. Mertz D, et al. Populations at risk for severe or complicated influenza illness: systematic review and metaanalysis. British Medical Journal 2013; 347: f5061.
33. Heikkinen T, et al. Burden of influenza in children in the community. Journal of Infectious Disease 2004; 190: 1369-1373.
34. Mulpuru S, et al. Influenza infection screening tools fail to accurately predict influenza status for patients during pandemic H1N1 influenza season. Canadian Respiratory Journal 2013; 20: e55-59.
35. Michiels B, et al. Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: A cross sectional study. BMC Family Practice 2011; 12: 4.
36. Hawker JI, et al. Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: Analysis of a large database of primary care consultations. Journal of Antimicrobial Chemotherapy 2014; 69: 3423-3430.
37. Heikkinen T, et al. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children. Pediatric Infectious Disease Journal. 2013; 32: 669-674.